Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Targeting The BCR::ABL1 Kinase: Advances Beyond Imatinib In Chronic Myeloid Leukemia Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia Current Hematologic Malignancy Reports , May 2026 Naderi Z et al. Curr Hematol Malig Rep, April 2026 Link to full abstract Share Tweet Share Share